Saltar al contenido
Merck

Temporal expression of MOF acetyltransferase primes transcription factor networks for erythroid fate.

Science advances (2020-07-17)
Cecilia Pessoa Rodrigues, Josip Stefan Herman, Benjamin Herquel, Claudia Isabelle Keller Valsecchi, Thomas Stehle, Dominic Grün, Asifa Akhtar
RESUMEN

Self-renewal and differentiation of hematopoietic stem cells (HSCs) are orchestrated by the combinatorial action of transcription factors and epigenetic regulators. Here, we have explored the mechanism by which histone H4 lysine 16 acetyltransferase MOF regulates erythropoiesis. Single-cell RNA sequencing and chromatin immunoprecipitation sequencing uncovered that MOF influences erythroid trajectory by dynamic recruitment to chromatin and its haploinsufficiency causes accumulation of a transient HSC population. A regulatory network consisting of MOF, RUNX1, and GFI1B is critical for erythroid fate commitment. GFI1B acts as a Mof activator which is necessary and sufficient for cell type-specific induction of Mof expression. Plasticity of Mof-depleted HSCs can be rescued by expression of a downstream effector, Gata1, or by rebalancing acetylation via a histone deacetylase inhibitor. Accurate timing and dosage of Mof expression act as a rheostat for the feedforward transcription factor network that safeguards progression along the erythroid fate.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti--actina antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Iron Stain
Sigma-Aldrich
Anticuerpo anti-acetil-histona H4 (Lys16), Upstate®, from rabbit
Sigma-Aldrich
Anti-acetyl-Histone H4 (Lys16) Antibody, Alexa Fluor 488, from rabbit, ALEXA FLUOR 488